Loading clinical trials...
Loading clinical trials...
Co-Administration of GSK Biologicals' Meningococcal Vaccine GSK134612 With Infanrix Hexa™, Compared to Individual Administration of Each Vaccine, in Healthy 12- Through 23-Month-Old Children
Conditions
Interventions
Meningococcal vaccine GSK134612
Infanrix™ hexa
+1 more
Locations
89
Austria
GSK Investigational Site
Eferding, Austria
GSK Investigational Site
Neufeld/Leitha, Austria
GSK Investigational Site
Salzburg, Austria
GSK Investigational Site
Villach, Austria
GSK Investigational Site
Wels, Austria
GSK Investigational Site
Bönnigheim, Baden-Wurttemberg, Germany
Start Date
August 1, 2007
Primary Completion Date
May 26, 2008
Completion Date
October 27, 2008
Last Updated
January 24, 2019
NCT04886154
NCT01962207
NCT01755689
NCT00974363
NCT00126984
NCT00196963
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions